We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WELL icon
1651
Welltower
WELL
$171B
– –
-7,123
Closed -$552K
WES icon
1652
Western Midstream Partners
WES
$19.3B
– –
-771
Closed -$24K
WFC icon
1653
Wells Fargo
WFC
$264B
– –
-467,220
Closed -$22.6M
WGO icon
1654
Winnebago Industries
WGO
$909M
– –
-548
Closed -$17K
WH icon
1655
Wyndham Hotels & Resorts
WH
$5.48B
– –
-1,800
Closed -$90K
WK icon
1656
Workiva
WK
$3.54B
– –
-451
Closed -$23K
WLY icon
1657
John Wiley & Sons Class A
WLY
$2.66B
– –
-3,931
Closed -$174K
WMS icon
1658
Advanced Drainage Systems
WMS
$11B
– –
-6,324
Closed -$163K
WPP icon
1659
WPP
WPP
$5.94B
– –
-8,331
Closed -$440K
WRB icon
1660
W.R. Berkley
WRB
$26.6B
– –
-5,400
Closed -$136K
WSFS icon
1661
WSFS Financial
WSFS
$4.15B
– –
-868
Closed -$34K
WSM icon
1662
Williams-Sonoma
WSM
$29.6B
– –
-2,000
Closed -$56K
WSR
1663
DELISTED
Whitestone REIT
WSR
– –
-600
Closed -$7K
WTI icon
1664
W&T Offshore
WTI
$518M
– –
-153,960
Closed -$1.06M
WTRG icon
1665
Essential Utilities
WTRG
$11.4B
– –
-5,181
Closed -$189K
WTW icon
1666
Willis Towers Watson
WTW
$32B
– –
-22,708
Closed -$3.99M
WVE icon
1667
Wave Life Sciences
WVE
$1.2B
– –
-220,321
Closed -$8.56M
WWW icon
1668
Wolverine World Wide
WWW
$1.55B
– –
-14,141
Closed -$505K
WY icon
1669
Weyerhaeuser
WY
$18.4B
– –
-83,010
Closed -$2.19M
X
1670
DELISTED
US Steel
X
– –
-35,580
Closed -$693K
XBIT icon
1671
XBiotech
XBIT
$69.2M
– –
-215
Closed -$2K
XERS icon
1672
Xeris Biopharma Holdings
XERS
$1.37B
– –
-7,087
Closed -$71K
XPO icon
1673
XPO
XPO
$23.7B
– –
-294,298
Closed -$5.47M
YEXT icon
1674
Yext
YEXT
$574M
– –
-160,106
Closed -$3.5M
YMAB
1675
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-735
Closed -$19K
65 66
67
68 69

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.